Novel biomarkers including D-dimer, fibrinogen (Fbg), alpha-defensin, and interleukin-6 (IL-6) have been introduced to improve the diagnostic criteria of PJI [6]. The gene discussed is IL6; the disease is juvenile polyposis syndrome.